MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0101002

Медицинская библиотека · PloS one · 2014

Anti-HDV IgM as a marker of disease activity in hepatitis delta.

Wranke Anika, Heidrich Benjamin, Ernst Stefanie, Calle Serrano Beatriz, Caruntu Florin Alexandru, Curescu Manuela Gabriela, Yalcin Kendal, Gürel Selim, Zeuzem Stefan, Erhardt Andreas, Lüth Stefan, Papatheodoridis George V, Bremer Birgit, Stift Judith, Grabowski Jan, Kirschner Janina, Port Kerstin, Cornberg Markus, Falk Christine S, Dienes Hans-Peter, Hardtke Svenja, Manns Michael P, Yurdaydin Cihan, Wedemeyer Heiner, HIDIT-2 Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker.

METHODS

Samples of 120 HDV-infected patients recruited in an international multicenter treatment trial (HIDIT-2) were studied. Anti-HDV IgM testing was performed using ETI-DELTA-IGMK-2-assay (DiaSorin). In addition, fifty cytokines, chemokines and angiogenetic factors were measured using multiplex technology (Bio-Plex System). A second independent cohort of 78 patients was studied for the development of liver-related clinical endpoints (decompensation, HCC, liver transplantation or death; median follow up of 3.0 years, range 0.6-12).

RESULTS

Anti-HDV IgM serum levels were negative in 18 (15%), low (OD<0.5) in 76 (63%), and high in 26 (22%) patients of the HIDIT-2 cohort. Anti-HDV IgM were significantly associated with histological inflammatory (p<0.01) and biochemical disease activity (ALT, AST p<0.01). HDV replication was independent from anti-HDV IgM, however, low HBV-DNA levels were observed in groups with higher anti-HDV IgM levels (p<0.01). While high IP-10 (CXCL10) levels were seen in greater groups of anti-HDV IgM levels, various other antiviral cytokines were negatively associated with anti-HDV IgM. Associations between anti-HDV IgM and ALT, AST, HBV-DNA were confirmed in the independent cohort. Clinical endpoints occurred in 26 anti-HDV IgM positive patients (39%) but in only one anti-HDV IgM negative individual (9%; p = 0.05).

CONCLUSIONS

Serum anti-HDV IgM is a robust, easy-to-apply and relatively cheap marker to determine disease activity in hepatitis delta which has prognostic implications. High anti-HDV IgM levels may indicate an activated interferon system but exhausted antiviral immunity.

Для цитирования: Wranke Anika, Heidrich Benjamin, Ernst Stefanie, Calle Serrano Beatriz, Caruntu Florin Alexandru, Curescu Manuela Gabriela, Yalcin Kendal, Gürel Selim, Zeuzem Stefan, Erhardt Andreas, Lüth Stefan, Papatheodoridis George V, Bremer Birgit, Stift Judith, Grabowski Jan, Kirschner Janina, Port Kerstin, Cornberg Markus, Falk Christine S, Dienes Hans-Peter, Hardtke Svenja, Manns Michael P, Yurdaydin Cihan, Wedemeyer Heiner, HIDIT-2 Study Group. Anti-HDV IgM as a marker of disease activity in hepatitis delta.. PloS one. 2014. DOI: 10.1371/journal.pone.0101002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.